Carl Zeiss secures sale of Acri.Tec

Article

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

Acri.Tec, which generated sales revenues of €15.4 million in the 2006 financial year, specializes in innovative implants for ophthalmic surgery. The two companies' products complement each other well and the acquisition will expand Carl Zeiss Meditec's rapidly-growing ophthalmic surgery division.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.